AVYCAZ | Market Exclusivity | US | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

AVYCAZ
US Exclusivities

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

AVYCAZ

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

40 API Suppliers, 18 USDMF, 16 CEP/COS, 6 JDMF, 4 EU WC, 4 KDMF, 4 NDC API, 15 Listed Suppliers, $ API Reference Price

40 API Suppliers
18 USDMF
16 CEP/COS
6 JDMF
4 EU WC
4 KDMF
4 NDC API
15 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

INTERMEDIATES

7 Intermediate Suppliers

7 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

222 FDF Dossiers, 42 FDA Orange Book, 100 Europe, 6 Canada, 16 South Africa, 58 Listed Dossiers

222 FDF Dossiers
42 FDA Orange Book
100 Europe
6 Canada
16 South Africa
58 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

POWDER;INTRAVENOUS - EQ 0.5GM BASE;2GM/VIAL, INJECTABLE;INJECTION - 1GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 2GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 6GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 20MG BASE/ML, INJECTABLE;INJECTION - EQ 40MG BASE/ML, INJECTABLE;INJECTION - EQ 1GM BASE, INJECTABLE;INJECTION - EQ 2GM BASE

POWDER;INTRAVENOUS - EQ 0.5GM BASE;2GM/VIAL
INJECTABLE;INJECTION - 1GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
INJECTABLE;INJECTION - 2GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
INJECTABLE;INJECTION - 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
INJECTABLE;INJECTION - 6GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
INJECTABLE;INJECTION - EQ 20MG BASE/ML
INJECTABLE;INJECTION - EQ 40MG BASE/ML
INJECTABLE;INJECTION - EQ 1GM BASE
INJECTABLE;INJECTION - EQ 2GM BASE

RELATED EXCIPIENT COMPANIES

1 Actylis, 1 Kerry, 1 Microlex e.U, 1 Pluviaendo, 1 Roquette

1 Actylis
1 Kerry
1 Microlex e.U
1 Pluviaendo
1 Roquette

EXCIPIENTS BY APPLICATIONS

2 Fillers, Diluents & Binders, 2 Parenteral, 1 Taste Masking, 1 Co-Processed Excipients

2 Fillers, Diluents & Binders
2 Parenteral
1 Taste Masking
1 Co-Processed Excipients

DIGITAL CONTENT

25 NEWS #PharmaBuzz

25 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 82 Finished Drug Prices, 8 Annual Reports

3 US Medicaid Prescriptions
82 Finished Drug Prices
8 Annual Reports

MARKET PLACE

22 APIs, 20 FDF Dossiers

22 APIs
20 FDF Dossiers

PATENTS & EXCLUSIVITIES

10 US Patents, 4 US Exclusivities, 16 Health Canada Patents

10 US Patents
4 US Exclusivities
16 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 2 USP, 4 Others

2 EDQM
2 USP
4 Others

$ API Ref.Price (USD/KG) : 374 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Name Reset all filters

4 All

01 4ABBVIE

filter Product Reset all filters

4 All

01 4AVIBACTAM SODIUM; CEFTAZIDIME

filter Exclusivity Expiration Date Reset all filters

4 All

01 12020-02-25

02 12025-02-25

03 12025-12-20

04 12027-01-26

filter Exclusivity Code Reset all filters

4 All

01 1GAIN

02 1NCE

03 2NPP

Product Main Page

ABBVIE

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Contact Supplier

Contact Supplier

Digital Content

AVIBACTAM SODIUM; CEFTAZIDIME

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

NCE

Exclusivity Expiration Date

2020-02-25

Application Number

206494

Product Number

1

Exclusivity Details

Abbvie Company Banner

01

ABBVIE

U.S.A

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

AVIBACTAM SODIUM; CEFTAZIDIME

Exclusivity Code : NCE

Exclusivity Expiration Date : 2020-02-25

Application Number : 206494

Product Number : 1

Exclusivity Details :

Abbvie Company Banner

Product Web Link

Digital Content

Corporate PDF

ABBVIE

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Contact Supplier

Contact Supplier

Digital Content

AVIBACTAM SODIUM; CEFTAZIDIME

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

GAIN

Exclusivity Expiration Date

2025-02-25

Application Number

206494

Product Number

1

Exclusivity Details

Abbvie Company Banner

02

ABBVIE

U.S.A

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

AVIBACTAM SODIUM; CEFTAZIDIME

Exclusivity Code : GAIN

Exclusivity Expiration Date : 2025-02-25

Application Number : 206494

Product Number : 1

Exclusivity Details :

Abbvie Company Banner

Product Web Link

Digital Content

Corporate PDF

ABBVIE

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Contact Supplier

Contact Supplier

Digital Content

AVIBACTAM SODIUM; CEFTAZIDIME

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

NPP

Exclusivity Expiration Date

2025-12-20

Application Number

206494

Product Number

1

Exclusivity Details

Abbvie Company Banner

03

ABBVIE

U.S.A

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

AVIBACTAM SODIUM; CEFTAZIDIME

Exclusivity Code : NPP

Exclusivity Expiration Date : 2025-12-20

Application Number : 206494

Product Number : 1

Exclusivity Details :

Abbvie Company Banner

Product Web Link

Digital Content

Corporate PDF

ABBVIE

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Contact Supplier

Contact Supplier

Digital Content

AVIBACTAM SODIUM; CEFTAZIDIME

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

NPP

Exclusivity Expiration Date

2027-01-26

Application Number

206494

Product Number

1

Exclusivity Details

Abbvie Company Banner

04

ABBVIE

U.S.A

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

AVIBACTAM SODIUM; CEFTAZIDIME

Exclusivity Code : NPP

Exclusivity Expiration Date : 2027-01-26

Application Number : 206494

Product Number : 1

Exclusivity Details :

Abbvie Company Banner

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!